Clinical Trial Update: Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating pre-reinductive decitabine and vorinostat in relapsed lymphoblastic lymphoma or acute lymphoblastic leukemia was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Decitabine (Decitabine)
• Vorinostat (vorinostat)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia, Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2016-10-28